ResMed Stock Forecast

Stock Price Forecast

The 10 analysts that cover ResMed stock have a consensus rating of "Buy" and an average price target of $293.7, which forecasts a 18.85% increase in the stock price over the next year. The lowest target is $265 and the highest is $345.

Price Target: $293.7 (+18.85%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$265	$293.7	$299	$345
Change	+7.24%	+18.85%	+21.00%	+39.61%

* Price targets were last updated on Feb 2, 2026.

Analyst Ratings

The average analyst rating for ResMed stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	2	2	2	2	2	2
Buy	5	6	5	5	5	5
Hold	4	4	5	5	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	12	12	12	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Laura Sutcliffe Citigroup	Citigroup	Strong Buy Maintains $330 → $345	Strong Buy	Maintains	$330 → $345	+39.61%	Feb 2, 2026
Craig Wong-Pan RBC Capital	RBC Capital	Buy Maintains $311 → $314	Buy	Maintains	$311 → $314	+27.07%	Jan 30, 2026
Adam Maeder Piper Sandler	Piper Sandler	Hold Maintains $270 → $275	Hold	Maintains	$270 → $275	+11.29%	Jan 30, 2026
Nathan Treybeck Wells Fargo	Wells Fargo	Hold Maintains $265 → $270	Hold	Maintains	$265 → $270	+9.26%	Jan 30, 2026
Jonathan Block Stifel	Stifel	Hold Maintains $260 → $265	Hold	Maintains	$260 → $265	+7.24%	Jan 30, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

5.69B

from 5.15B

10.64%

from 5.15B

Revenue Next Year

6.11B

from 5.69B

7.38%

from 5.69B

EPS This Year

11.12

from 9.51

16.89%

from 9.51

EPS Next Year

12.28

from 11.12

10.46%

from 11.12

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	3.20B	3.58B	4.22B	4.69B	5.15B	5.69B	6.11B
Revenue Growth	8.11%	11.93%	18.02%	10.95%	9.84%	10.64%	7.38%
EPS	3.24	5.30	6.09	6.92	9.51	11.12	12.28
EPS Growth	-24.12%	63.58%	14.91%	13.63%	37.43%	16.89%	10.46%
Forward PE	-	-	-	-	-	22.23	20.12
No. Analysts	-	-	-	-	-	22	22

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	6.0B	6.5B
Avg	5.7B	6.1B
Low	5.5B	5.8B

Revenue Growth

Revenue Growth	2026	2027
High	15.8%	13.8%
Avg	10.6%	7.4%
Low	6.6%	2.4%

EPS Forecast

EPS	2026	2027
High	11.78	13.40
Avg	11.12	12.28
Low	10.14	11.47

EPS Growth

EPS Growth	2026	2027
High	23.9%	20.5%
Avg	16.9%	10.5%
Low	6.7%	3.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.